Browsing by Ajou Author

최, 진혁(Choi, Jin Hyuk) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Hematology-Oncology]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 21 to 40 of 95

This table browses all dspace content
Pub YearTitleAuthor(s)
2019Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer최진혁
2019The role of surgical resection before palliative chemotherapy in advanced gastric cancer강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈
2018Should combination chemotherapy be used in all advanced gastric cancer patients?강석윤, 안미선, 이현우, 최용원, 최진혁
2018Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy강석윤, 안미선, 이현우, 최용원, 최진혁
2018P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study최진혁
2018469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁
2018EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호
2018Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호
2018The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁
2017Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?최용원, 최진혁
2017Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes강석윤, 임현이, 전미선, 정용식, 최진혁, 한세환
2016The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer박광주, 안영실, 오영택, 윤준기, 이수진, 최진혁
2016Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer노오규, 박래웅, 박성용, 안미선, 오영택, 윤덕용, 이현우, 전미선, 최진혁, 허재성
2016High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호
2016Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments강석윤, 김상원, 전미선, 정용식, 최진혁, 한세환
2016Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancer고영화, 안미선, 이현우, 최용원, 최진혁
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)강석윤, 최진혁
2015Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁
2015Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁
2015Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.최진혁
1 2 3 4 5

Browse